logo
Select company
Select metric
$ 886KCapital Expenditure
VS
Market
70
Sector
43
Industry
27
History
-
$ 15.31Close
$ 5.79 - $ 23.97 52-Week Range
Ticker Information

Ticker

MBX

Company Name

MBX BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MBX BIOSCIENCES INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MBX - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 886K
12/31/2024$ 874K
12/31/2023$ 129K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MBX BIOSCIENCES INC's latest trailing twelve months (TTM) CapEx stands at $ 129K.
  • Over the past 5 years, MBX BIOSCIENCES INC's average CapEx has been $ 629.67K.
  • The median CapEx for MBX BIOSCIENCES INC during this period was $ 874K
  • MBX BIOSCIENCES INC reached its highest CapEx over the past 5 years at $ 886K.
  • The lowest CapEx recorded by MBX BIOSCIENCES INC in the same timeframe $ 129K

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

MBX - Capital Expenditure, Last 5 years

$ 129K

Minimum

Dec 31, 2023

$ 886K

Maximum

Jun 30, 2025

$ 629.67K

Average

$ 874K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.65M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.65M
median$ 1.92M
std$ 15.86M